PLEASE FIND THE BEST THREE POSTERS OF THE CONGRESS BELOW:
EACH POSTER HAS BEEN AWARDED 500 EURO PRIZE
PLEASE CONTACT CONGRESS SECRETARIAT TO CLAIM YOUR PRIZE MONEY
2ND PLACE:
Poster No.120
Title: Blockade of programmed death-1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes, but may enhance tumour proliferation
Authors:Ieva Saulite, Desislava Ignatova, Yun-Tsan Chang, Christina Fassnacht, Eleni Varypataki, Florian Anzengruber, Mirjam Nägeli, Antonio Cozzio, Reinhard Dummer, Julia Scarisbrick, Steve Pascolo, Wolfram Hoetzenecker, Malgorzata Bobrowicz, Emmanuella Guenova;
Poster No.35
Title: Tirbanibulin, a Novel Inhibitor of Tubulin Polymerisation and Src Kinase Signalling, for Actinic Keratosis: Results from two Phase III Studies
Authors: Andrew Blauvelt, Steven Kempers, Seth Forman, Edward Lain, Suzanne Bruce, Glynis Ablon, Abel Jarell, Michael Bukhalo, Robert Lieberman, Jane Fang, Tirbanibulin Phase III Study Group;
Poster No.94
Title: Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 MAVORIC Study
Authors:Youn Kim, Martine Bagot, Pier Luigi Zinzani, Stephen Morris, Pablo Ortiz-Romero, Nina Magnolo, Julia Scarisbrick, Stéphane Dalle, Pietro Quaglino, Brigitte Dréno, Marie Beylot-Barry, Dolores Caballero, Richard Cowan,Reinhard Dummer, Lars Iversen, Maarten Vermeer, Jan Nicolay
Poster No.120
Title: Blockade of programmed death-1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes, but may enhance tumour proliferation
Authors:Ieva Saulite, Desislava Ignatova, Yun-Tsan Chang, Christina Fassnacht, Eleni Varypataki, Florian Anzengruber, Mirjam Nägeli, Antonio Cozzio, Reinhard Dummer, Julia Scarisbrick, Steve Pascolo, Wolfram Hoetzenecker, Malgorzata Bobrowicz, Emmanuella Guenova;
Poster No.32
Title: Next Generation Sequencing analysis of intratumoral heterogeneity in melanoma: Influence of BRAFV600E frequency in histopathologic tumor characteristics
Authors: Soria X; Macià A; Barceló C; Maiques O; Sisó P; Cuevas D; Velasco A; De la Rosa I; Matias-Guiu X; Vilardell F; Martí RM;
Poster No.53
Title: Survival of Melanoma in possession of innovative therapies, a single institute retrospective study
Authors:Timea Danyi, Balatoni Timea, Pánczél Gitta, Czirbesz Kata, Imrédi Eleonora, Baranyai Fanni, Kispál Mihály, Bőcs Katalin, Tóth Erika, Fröhlich Georgina, Liszkay Gabriella;
Poster No.62
Title: Characteristics of patients (pts) with a complete response (CR) treated with dabrafenib plus trametinib (D+T) combination therapy: Findings from COMBI-d and COMBI-v 5-year analysis
Authors: Caroline Robert, Jean Jacques Grob, Daniil Stroyakovskiy, Boguslawa Karaszewska, Axel Hauschild, Evgeny Levchenko, Vanna Chiarion Sileni, Jacob Schachter, Claus Garbe, Igor Bondarenko, Paul Nathan,
Antoni Ribas, Michael A. Davies, Keith Flaherty, Paul Burgess, Monique Tan, Eduard Gasal, Dirk Schadendorf, Georgina V. Long;
Poster No.79
Title: Prediction of melanoma relapse-free survival (RFS) in patients with completely resected, BRAF V600E/K–mutant, stage III cutaneous melanoma
Authors:Mario Mandalà, Dirk Schadendorf, Reinhard Dummer, Axel Hauschild, Mario Santinami, John M. Kirkwood, Caroline Robert, Georgina V. Long, Vanna Chiarion Sileni, James Larkin, Marta Nyakas, Andrew Haydon,
Caroline Dutriaux, Jacob Schachter, Laurent Mortier, Thierry Lesimple, Elizabeth Plummer, Eduard Gasal,Silvia Colicino, Mike Lau, Monique Tan, Victoria Atkinson;
Poster No.93
Title: Identification of patients with T1-T2 melanoma and low risk of sentinel lymph node positivity using a 31-gene expression profile test
Authors: Federico A. Monzon, MD, FCAP; Robert W. Cook, PhD; Hillary G. Caruso, PhD; Kyle R. Covington, PhD; Deri Lewis, MD; Eric Whitman, MD, FACS; David M. Hyams, MD, FACS;
Poster No.96
Title: Decreasing Melanoma Incidence in Subjects Under 40 Years of Age in a Spanish University Hospital
Authors:Álvaro Gómez-Tomás, Domingo Bodet-Castillo, Patricia Bassas-Freixas, Carla Ferrándiz-Pulido, Carlos González-Cruz, Víctor Cabezas-Calderón, Marta Velasco-Guidonet, Pablo Castro-García, Vicente García-Patos;
Poster No.119
Title: First experiences with brentuximab vedotin in CD30+ cutaneous T-cell lymphoma
Authors:Ildikó Csányi, Henriette Ócsai, Anita Varga, Irma Korom, Erika Varga, László Krenács, Katalin Hideghéty, Timea Gurbity Pálfi, Zita Borbányi, Márta Marschalkó, Anna Tremmel, Lajos Kemény, Judit Oláh, Eszter Baltás;